J&J hires Bayer exec to oversee quality; Pfizer adding 600 to operations in China;

> Johnson & Johnson ($JNJ) hired former Bayer executive Sandra Peterson to oversee its troubled consumer health unit and manufacturing operations. Story

> Johnson & Johnson's Ethicon will invest $185 million to build a new plant in Athens, GA, to make sutures. Story

> Medical device maker Covidien ($COV) told its 595 employees at a plant in Seneca, SC, that the facility will be closed within three years and production moved to a plant in Costa Rica. Story

> Xcelience says it is opening a 24,000-square-foot facility in Tampa, FL, for  secondary packaging, labeling, distribution and warehouse services. Item

> The FDA cited French in vitro diagnostics player bioMérieux for a number of quality violations in a North Carolina manufacturing facility. Story

And Finally... The joint venture of Pfizer ($PFE) and Zhejiang Hisun Pharmaceutical will hire 600 people in China by the end of the year for manufacturing as well as R&D and support functions. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.